SCHEMBL493375

SCHEMBL493375

CN(C)C(c1cccc(F)c1)C1CCC(NC(=O)COCCNS(=O)(=O)c2ccccc2Cc2ccccc2)CC1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 3/20 0.36
PKM P14618 1/20 0.36
TSHR P16473 1/20 0.36
TACR3 P29371 2/20 0.35
OPRM1 P35372 2/20 0.34
SIGMAR1 Q99720 2/20 0.34
RAB9A P51151 1/20 0.33
BRD4 O60885 1/20 0.33
CNR2 P34972 2/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
CNR1 P21554 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
SLC6A2 P23975 1/20 0.33
SLC6A4 P31645 1/20 0.33
SLC6A3 Q01959 1/20 0.33
KCNH2 Q12809 1/20 0.33
SGMS1 Q86VZ5 1/20 0.32
MEN1 O00255 1/20 0.32
KMT2A Q03164 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL493050 0.93 RAB9A (0.37) TSHRRAB9ACNR2SMN1; SMN2CNR1
SCHEMBL492676 0.92 CNR1 (0.35) TSHRSIGMAR1RAB9ACNR2SMN1; SMN2
SCHEMBL493355 0.90 PTGIR (0.37) OPRL1TACR3OPRM1SGMS1KMT2A
SCHEMBL492995 0.89 OPRL1 (0.35) OPRL1TACR3OPRM1CNR2CYP2D6
SCHEMBL492463 0.84 SMN1; SMN2 (0.38) OPRL1TSHROPRM1SIGMAR1RAB9A
SCHEMBL493525 0.83 POLB (0.39) PKMRAB9ACYP3A4CYP2D6SLC6A2
SCHEMBL492939 0.82 PTGIR (0.39) MEN1KMT2A
SCHEMBL492240 0.82 PTGIR (0.36) SGMS1MEN1KMT2A
SCHEMBL492259 0.81 SGMS1 (0.33) SLC6A2SLC6A4SLC6A3SGMS1MEN1
SCHEMBL493344 0.81 OPRL1 (0.45) OPRL1PKMTSHROPRM1SIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD OPRL1 4/4885PKM 1161/4885TSHR 4051/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.